Gerd Sutter

LMU Klinikum — Germany

Immunology and Microbiology · Life Sciences

62h-index13.3kcitations277works5.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Poxvirus research and outbreaks(83), Virus-based gene therapy research(80), Herpesvirus Infections and Treatments(61), Immunotherapy and Immune Responses(58), SARS-CoV-2 and COVID-19 Research(43)

Publications276 total

Strong immunogenicity and protection against SARS-CoV-2 in hamsters induced by heterologous boost vaccination with an MVA-based COVID-19 vaccine candidate
Journal of General Virology·2025Open Access
Systems Vaccinology Reveals Distinct Immune Signatures of Inhaled and Intramuscular SARS-CoV-2 Vaccination in Humans
2025Open Access
Inhaled booster vaccination with an MVA-based SARS-CoV-2 vaccine candidate induces T cell responses in lung
2025Open Access
Phase 1 Study of Safety, Reactogenicity, and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate Administered as Inhalation Boost in SARS-CoV-2 Immunized Adults
2025· 1 citedOpen Access
Robust polyfunctional CD8+ and CD4+ T cell responses in HLA-A*0201/DR1 transgenic mice following vaccination with modified vaccinia virus Ankara-based vaccines delivering Lassa virus glycoprotein or nucleoprotein
Journal of General Virology·2025· 2 citedOpen Access
Pharmacokinetics, Safety, and Dialyzability of Gadoquatrane in Patients With Impaired Renal Function
Investigative Radiology·2025· 1 citedOpen Access
Design and evaluation of a poly-epitope based vaccine for the induction of influenza A virus cross-reactive CD8 + T cell responses
Scientific Reports·2025· 3 citedOpen Access
Efficacy of emergency maternal MVA-ZIKV vaccination in a rapid challenge model of lethal Zika infection
npj Vaccines·2025· 1 citedOpen Access
A Brighton collaboration standardized template with key considerations for a benefit/risk assessment for a viral vector vaccine based on a non-replicating modified vaccinia virus Ankara viral vector
Vaccine·2024· 1 citedOpen Access
Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans
Vaccines·2024· 4 citedOpen Access
Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study
International Journal of Molecular Sciences·2024· 3 citedOpen Access
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
The Lancet Infectious Diseases·2024· 14 citedOpen Access
Multi-omics characterization of the monkeypox virus infection
Nature Communications·2024· 52 citedOpen Access
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach
iScience·2024· 3 citedOpen Access
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses
Molecular Therapy·2024· 10 citedOpen Access
Pharmacokinetics, safety, and tolerability of the novel tetrameric gadolinium-based MRI contrast agent gadoquatrane in healthy Chinese and Japanese men: Two randomized dose-escalation studies including concentration–QTc modeling
European Journal of Pharmaceutical Sciences·2024· 7 citedOpen Access
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
Viruses·2024· 4 citedOpen Access
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
npj Vaccines·2024· 11 citedOpen Access
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection
Vaccines·2024· 3 citedOpen Access
Identification of a Spike-Specific CD8+ T-Cell Epitope Following Vaccination Against the Middle East Respiratory Syndrome Coronavirus in Humans
The Journal of Infectious Diseases·2024· 1 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Ingo Drexler(12), Asisa Volz(10), Volker Erfle(10), Caroline Staib(8), Robert Fux(7), Bernard Moss(5), Albert D. M. E. Osterhaus(5), Reinhold Förster(4), Bart L. Haagmans(4), Stephan Becker(4), Joost H. C. M. Kreijtz(4), Guus F. Rimmelzwaan(4), Holger Ludwig(3), David C. Montefiori(3), Yasemin Suezer(3), Nisreen M.A. Okba(3), Ulrich Kalinke(3), Chenxi Wang(3), David B. Allison(3), David I. Watkins(3)